IGF2 and hepatocellular carcinoma: Increasing evidence shows that IGF1R and its ligands (IGF‐1, IGF‐2) play an important role in the development and progression of several cancers, including hepatocellular carcinoma (HCC) (Aleem et al, 2011; Pollak, 2012).